Log in to save to my catalogue

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome an...

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7808b5d0d78d41449b9f048d30c6fc39

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

About this item

Full title

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

Publisher

England: BioMed Central Ltd

Journal title

Genome medicine, 2023-10, Vol.15 (1), p.82-82, Article 82

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Prostate cancer (PrCa) genomic heterogeneity causes resistance to therapies such as androgen deprivation. Such heterogeneity can be deciphered in the context of evolutionary principles, but current clinical trials do not include evolution as an essential feature. Whether or not analysis of genomic data in an evolutionary context in primary prostate...

Alternative Titles

Full title

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7808b5d0d78d41449b9f048d30c6fc39

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7808b5d0d78d41449b9f048d30c6fc39

Other Identifiers

ISSN

1756-994X

E-ISSN

1756-994X

DOI

10.1186/s13073-023-01242-y

How to access this item